Health Care — Senate Democrats call for answers on infant RSV drug shortage

Presented by Express Scripts by Evernorth — Lawmakers are demanding answers from manufacturers

View Online Health Care Health Care PRESENTED BY  The Big Story  Senators press manufacturers over infant RSV drug shortage A group of Senate Democrats is pressing drug companies for answers about a nationwide shortage of a new injection that prevents respiratory syncytial virus (RSV) in infants.  © National Institute of Allergy and Infectious Diseases, NIH via AP In a letter led by Sen. Tammy Duckworth (D-Ill.) sent Friday, the lawmakers asked manufacturers AstraZeneca and Sanofi for more information about the current supply of nirsevimab, when the companies first became aware of the shortage, and why they were so unprepared for the demand.  "As our nation braces for the 2023-2024 RSV season, we are concerned that health care providers and families are having difficulty accessing this new immunization product that can be used to prevent severe RSV infections in infants," the senators wrote.  The letter comes the day after the Centers for Disease Control and Prevention said it was expediting the release of an additional 77,000 doses, though the additional supplies likely won't be enough to meet demand.  Nirsevimab, marketed as Beyfortus, is a monoclonal antibody rather than a traditional vaccine, meaning babies will be able to directly receive antibodies to prevent severe RSV, rather than prompting the immune system to develop them.  The drug is one of two available treatments in the U.S. that can protect infants from RSV, which is the leading cause of hospitalization among babies nationwide. It cuts the risk of hospitalizations in infants by about 80 percent and was hailed as a game changer.  But shortages of Beyfortus have been plaguing the country since it was approved earlier this year. Pediatricians and hospitals have been struggling to stock the immunization due to what Sanofi said was "unprecedented" demand.  A representative from Sanofi told the American Academy of Pediatrics earlier this month that demand for the 100-milligram (mg) doses, for infants who weigh more than 11 pounds, exceeded the supply meant for the entire season within weeks of shipping.  Welcome to The Hill's Health Care newsletter, I'm Nathaniel Weixel — every week we follow the latest moves on how Washington impacts your health. Did someone forward you this newsletter? Subscribe here. Essential Reads  How policy will be impacting the health care sector this week and beyond: White House taps Vanderbilt oncologist to lead National Cancer Institute The White House on Friday said it plans to appoint W. Kimryn Rathmell as the next director of the National Cancer Institute (NCI), the federal government’s principal agency for cancer research.  Rathmell is an oncologist and kidney cancer expert who leads the Vanderbilt University Medical Center in Nashville, Tenn. As leader of the NCI, Rathmell will be instrumental in helping the White House achieve the goals of …  Full Story CDC releases 77,000 additional doses of RSV shot for infants amid shortage The Centers for Disease Control and Prevention (CDC) said it was releasing 77,000 additional doses of a respiratory syncytial virus (RSV) drug from Sanofi and AstraZeneca to help improve its availability.  The additional doses of Beyfortus will be distributed immediately to physicians and hospitals through the Vaccines for Children Program, which covers the cost of the shots for uninsured and underinsured kids, as well …  Full Story Rosalynn Carter enters hospice care Former first lady Rosalynn Carter, who was diagnosed with dementia earlier this year, has entered hospice care at home alongside former President Carter.  Full Story A MESSAGE FROM EXPRESS SCRIPTS BY EVERNORTH    Reimagining what's possible for the pharmacy benefit   Express Scripts by Evernorth redefines savings and transparency with clear prescription cost breakdowns. Learn More.   Around the Nation  Local and state headlines on health care: Effort to get legal psychedelics on Mass. ballot hits signature snag (WBUR)  A hospital's abrupt closure means, for many, help is distant (Washington Post)  Beyond insulin: Medi-Cal expands patient access to diabetes supplies (KFF Health News)  What We're Reading  Health news we've flagged from other outlets: COVID and flu vaccine rates are declining for U.S. health care workers, CDC reports: 'Disturbing trend' (Fox News)  The inescapable ad campaign for a wonky drug policy debate (Roll Call)  Doctors divide over reforming a secretive panel that determines their Medicare pay (Stat)  What Others are Reading  Most read stories on The Hill right now: Senate Republicans get ready to roll Tuberville on military holds  Republican senators are laying the groundwork to vote before Christmas on a Democratic-drafted resolution to circumvent the blockade that Alabama Sen. … Read more Judge denies Trump's mistrial motion in NY fraud case A New York judge has denied former President Trump’s motion for a mistrial in his civil fraud case, rejecting the claim that the judge and his … Read more What People Think  Opinions related to health submitted to The Hill: If Congress walks away from PEPFAR, it will undo decades of global HIV progress The physician-workforce pipeline is broken. Here's how to fix it.   You're all caught up. See you next week!  Check out The Hill's Health Care page for the latest coverage. Like this newsletter? Take a moment to view our other topical products here 📩 Privacy Policy  |  Manage Subscriptions  |  Unsubscribe  1625 K Street NW, 9th Floor, Washington, DC 20006 Copyright © 1998 - 2023 Nexstar Media Inc. | All Rights Reserved.

If you believe this has been sent to you in error, please safely unsubscribe.